Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles
Pneumonia is the main cause of hospital admission in COVID-19 patients. We aimed to perform an extensive characterization of clinical, laboratory, and cytokine profiles in order to identify poor outcomes in COVID-19 patients. Methods: A prospective and consecutive study involving 108 COVID-19 patien...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ecf9fad47b314df4b289d5e683192e3f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ecf9fad47b314df4b289d5e683192e3f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ecf9fad47b314df4b289d5e683192e3f2021-11-25T18:02:46ZPredictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles10.3390/jcm102254312077-0383https://doaj.org/article/ecf9fad47b314df4b289d5e683192e3f2021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5431https://doaj.org/toc/2077-0383Pneumonia is the main cause of hospital admission in COVID-19 patients. We aimed to perform an extensive characterization of clinical, laboratory, and cytokine profiles in order to identify poor outcomes in COVID-19 patients. Methods: A prospective and consecutive study involving 108 COVID-19 patients was conducted between March and April 2020 at Hospital Clínico Universitario de Valladolid (Spain). Plasma samples from each patient were collected after emergency room admission. Forty-five serum cytokines were measured in duplicate, and clinical data were analyzed using SPPS version 25.0. Results: A multivariate predictive model showed high hepatocyte growth factor (HGF) plasma levels as the only cytokine related to intubation or death risk at hospital admission (OR = 7.38, 95%CI—(1.28–42.4), <i>p</i> = 0.025). There were no comorbidities included in the model except for the ABO blood group, in which the O blood group was associated with a 14-fold lower risk of a poor outcome. Other clinical variables were also included in the predictive model. The predictive model was internally validated by the receiver operating characteristic (ROC) curve with an area under the curve (AUC) of 0.94, a sensitivity of 91.7% and a specificity of 95%. The use of a bootstrapping method confirmed these results. Conclusions: A simple, robust, and quick predictive model, based on the ABO blood group, four common laboratory values, and one specific cytokine (HGF), could be used in order to predict poor outcomes in COVID-19 patients.Óscar Gorgojo-GalindoMarta Martín-FernándezMaría Jesús Peñarrubia-PonceFrancisco Javier ÁlvarezChristian Ortega-LoubonHugo Gonzalo-BenitoPedro Martínez-PazJosé Pablo Miramontes-GonzálezEsther Gómez-SánchezRodrigo Poves-ÁlvarezPablo Jorge-MonjasEduardo TamayoMaría Heredia-RodríguezÁlvaro Tamayo-VelascoMDPI AGarticleCOVID-19HGFdiagnosiscytokinesbiomarkervalidationMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5431, p 5431 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
COVID-19 HGF diagnosis cytokines biomarker validation Medicine R |
spellingShingle |
COVID-19 HGF diagnosis cytokines biomarker validation Medicine R Óscar Gorgojo-Galindo Marta Martín-Fernández María Jesús Peñarrubia-Ponce Francisco Javier Álvarez Christian Ortega-Loubon Hugo Gonzalo-Benito Pedro Martínez-Paz José Pablo Miramontes-González Esther Gómez-Sánchez Rodrigo Poves-Álvarez Pablo Jorge-Monjas Eduardo Tamayo María Heredia-Rodríguez Álvaro Tamayo-Velasco Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles |
description |
Pneumonia is the main cause of hospital admission in COVID-19 patients. We aimed to perform an extensive characterization of clinical, laboratory, and cytokine profiles in order to identify poor outcomes in COVID-19 patients. Methods: A prospective and consecutive study involving 108 COVID-19 patients was conducted between March and April 2020 at Hospital Clínico Universitario de Valladolid (Spain). Plasma samples from each patient were collected after emergency room admission. Forty-five serum cytokines were measured in duplicate, and clinical data were analyzed using SPPS version 25.0. Results: A multivariate predictive model showed high hepatocyte growth factor (HGF) plasma levels as the only cytokine related to intubation or death risk at hospital admission (OR = 7.38, 95%CI—(1.28–42.4), <i>p</i> = 0.025). There were no comorbidities included in the model except for the ABO blood group, in which the O blood group was associated with a 14-fold lower risk of a poor outcome. Other clinical variables were also included in the predictive model. The predictive model was internally validated by the receiver operating characteristic (ROC) curve with an area under the curve (AUC) of 0.94, a sensitivity of 91.7% and a specificity of 95%. The use of a bootstrapping method confirmed these results. Conclusions: A simple, robust, and quick predictive model, based on the ABO blood group, four common laboratory values, and one specific cytokine (HGF), could be used in order to predict poor outcomes in COVID-19 patients. |
format |
article |
author |
Óscar Gorgojo-Galindo Marta Martín-Fernández María Jesús Peñarrubia-Ponce Francisco Javier Álvarez Christian Ortega-Loubon Hugo Gonzalo-Benito Pedro Martínez-Paz José Pablo Miramontes-González Esther Gómez-Sánchez Rodrigo Poves-Álvarez Pablo Jorge-Monjas Eduardo Tamayo María Heredia-Rodríguez Álvaro Tamayo-Velasco |
author_facet |
Óscar Gorgojo-Galindo Marta Martín-Fernández María Jesús Peñarrubia-Ponce Francisco Javier Álvarez Christian Ortega-Loubon Hugo Gonzalo-Benito Pedro Martínez-Paz José Pablo Miramontes-González Esther Gómez-Sánchez Rodrigo Poves-Álvarez Pablo Jorge-Monjas Eduardo Tamayo María Heredia-Rodríguez Álvaro Tamayo-Velasco |
author_sort |
Óscar Gorgojo-Galindo |
title |
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles |
title_short |
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles |
title_full |
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles |
title_fullStr |
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles |
title_full_unstemmed |
Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles |
title_sort |
predictive modeling of poor outcome in severe covid-19: a single-center observational study based on clinical, cytokine and laboratory profiles |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/ecf9fad47b314df4b289d5e683192e3f |
work_keys_str_mv |
AT oscargorgojogalindo predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT martamartinfernandez predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT mariajesuspenarrubiaponce predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT franciscojavieralvarez predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT christianortegaloubon predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT hugogonzalobenito predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT pedromartinezpaz predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT josepablomiramontesgonzalez predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT esthergomezsanchez predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT rodrigopovesalvarez predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT pablojorgemonjas predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT eduardotamayo predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT mariaherediarodriguez predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles AT alvarotamayovelasco predictivemodelingofpooroutcomeinseverecovid19asinglecenterobservationalstudybasedonclinicalcytokineandlaboratoryprofiles |
_version_ |
1718411715754852352 |